One key incentive for Pfizer paying $11 billion for Array BioPharma was the positive early readouts from its triplet therapy for colorectal cancer. Now, the biotech has shown exactly how attractive ...

The news that Array BioPharma’s clinical trial of its triplet therapy for colon cancer extended lives in a trial of patients with the BRAF mutation sent the company’s shares up 23% on Tuesday—a run ...

Many computational endeavors benefit from some form of parallelization, and SLURM provides a way to do “embarrassingly parallel” processing relatively simply (read more about parallelization).

The requirements of higher system bandwidth and resolution in a variety of applications from communications infrastructure to instrumentation drive up the demand for connecting multiple data ...

In recent articles we have looked at the extent of cloud storage products and services available. These have included the file, block and object storage available from the main cloud providers, and ...